Recently, HB TempCon independently developed RAP temperature controlled container has successfully completed the cross-border cold chain shipment mission from Shanghai to New York, marking the first time that this large-capacity container has entered the U.S. market.

The shipment carried high-value temperature-sensitive pharmaceuticals, enduring a 15-hour intercontinental flight. Throughout the journey, the RAP container maintained precision temperature control, ensuring the cargo remained within the optimal temperature range at all times—critical for preserving the efficacy and safety of life-saving medications.

HB TempCon active air temperature-controlled containers have already completed successful shipments to key global hubs including Chicago (USA), Frankfurt (Germany), Paris (France), Milan (Italy), Amsterdam (Netherlands), Mumbai (India), Seoul (South Korea), Jakarta (Indonesia), and Singapore.

As the global biopharmaceutical industry booms, HB TempCon remains committed to driving innovation as its core engine. We will continue to refine our full-lifecycle services covering R&D, production, operation, and maintenance, empowering more "Made-in-China" temperature-controlled containers to fly worldwide.

HB TempCon aspires to become the world’s leading active air temperature-controlled solutions provider. As specialists in air temperature control, we uphold the mission of "Green Tech, Better Life"—integrating environmental sustainability with high-efficiency temperature control technology to protect temperature-sensitive cargo globally. Guided by our core values of "User-Centricity" and "Honoring Strivers," we relentlessly pursue excellence in both products and services. We look forward to collaborating with partners worldwide to create a brighter, healthier future.